Development of a Novel Medication for Alcohol Use Disorder with an Active IND Dual Inhibitor of T-Type Calcium Channel and Soluble Epoxide Hydrolase
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2023 · $982,702
Sep 25, 2023 – Aug 31, 2025
Solicitation PAR22-102 (2022) · Topic 150
Accelerating the non-opioid analgesic AFA-281 clinical development with TABA-supported business development
SBIR Phase II · Department of Health and Human Services (National Institutes of Health) · 2023 · $3,049,862
Sep 21, 2023 – Apr 30, 2026
Solicitation PA20-272 (2020) · Topic NINDS
Developing a novel treatment of cocaine use disorder using an IND dual inhibitor of Cav3 channel and soluble epoxide hydrolase
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2023 · $319,547
Sep 15, 2023 – Sep 14, 2024
Solicitation DA23-021 (2023) · Topic NIDA
Development of a Next Generation Visual Performance Assessment System for Rodents
SBIR Phase II · Department of Health and Human Services (National Institutes of Health) · 2019 · $1,480,057
May 1, 2019 – Apr 30, 2021
Solicitation PA18-574 (2018) · Topic NEI
IND-enabling studies on novel Cav3 T-channel modulators for treatment of neuropathic pain
SBIR Phase II · Department of Health and Human Services (National Institutes of Health) · 2018 · $2,983,561
Sep 30, 2018 – May 31, 2021
Solicitation PAR17-480 (2017) · Topic NINDS
Discovering GIRK Channel Direct Activator as a Novel Chronic Insomnia Therapeutic
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2018 · $399,429
Sep 17, 2018 – Jul 31, 2020
Solicitation PA17-302 (2017) · Topic NHLBI
Development of patented tricyclic pyrones molecules for the treatment of Alzheimer's Disease
SBIR Phase II · Department of Health and Human Services (National Institutes of Health) · 2017 · $2,174,709
Mar 1, 2017 – Feb 29, 2020
Solicitation PA18-591 (2016) · Topic NIA
Sample-free onsite detection of cocaine using microneedles via laser-treated skin
STTR Phase I · Department of Health and Human Services (National Institutes of Health) · 2016 · $223,633
Aug 15, 2016 – Jul 31, 2018
Solicitation PA14-072 (2014) · Topic NIDA
Developing a novel CGRP antagonist for treatment of dental neuroinflammatory pain
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2016 · $221,872
Apr 1, 2016 – Mar 31, 2018
Solicitation PA15-269 (2015) · Topic NIDCR
A Visual Assessment System for Retinal Function/Drug Discovery
STTR Phase I · Department of Health and Human Services (National Institutes of Health) · 2015 · $233,235
Sep 1, 2015 – Aug 31, 2016
Solicitation PA14-072 (2015) · Topic N · Research partner: SCHEPENS EYE RESEARCH INSTITUTE
Development of selective Cav3 channel blockers for treatment of neuropathic pain
SBIR Phase II · Department of Health and Human Services (National Institutes of Health) · 2015 · $1,432,207
Jul 1, 2015 – Sep 29, 2018
Solicitation PA13-234 (2013) · Topic 108
Development of selective Cav3 channel blockers for treatment of neuropathic pain
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2014 · $1,657,206
Solicitation PA13-234 (2014) · Topic NINDS · Research partner: Stub
Development of Novel Tricyclic Pyrone Drugs for Treatment of Alzheimer Disease
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2013 · $596,058
Solicitation PA12-088 (2013) · Topic NIA
Development of an automated noninvasive system for sleep restriction in rodents
STTR Phase II · Department of Health and Human Services (National Institutes of Health) · 2013 · $852,597
Solicitation PA12-089 (2013) · Topic NHLBI · Research partner: PENNSYLVANIA STATE UNIV HERSHEY MED CTR
Nicotine delivery to rodent with lung alveolar region-targeted aerosol technology
SBIR Phase II · Department of Health and Human Services (National Institutes of Health) · 2013 · $990,659
Solicitation PA12-088 (2013) · Topic NIDA · Research partner: Stub
IGF::OT::IGF: FY13: Phenotypic Screening of Smoking Cessation Drugs, N43DA-13-7
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2013 · $338,884
Solicitation year 2013 · Topic NIDA · Research partner: Stub
Treat Neuropathic Pain with Dissolvable Microneedles Containing Anti-CGRP Peptide
SBIR Phase II · Department of Health and Human Services (National Institutes of Health) · 2012 · $979,131
Solicitation PA12-088 (2012) · Topic NIDA · Research partner: Stub
Nicotine delivery to rodents with lung alveolar region-targeted aerosol tech
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2011 · $240,384
Solicitation PA10-050 (2011) · Topic NIDA · Research partner: Stub
Development of automated neurobehavioral assay for rodent stroke model assessment
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2011 · $253,114
Solicitation PA08-071 (2011) · Topic NINDS · Research partner: Stub
Retrograde Tracers with Suicide Enzyme?Prodrug to Study Specific Neural Circuits
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2009 · $595,044
Solicitation PHS2009-2 (2009)
Microneedle patches deliver a CGRP antagonist for neurogenic inflammatory pain
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2008 · $199,171
Solicitation PHS2007-2 (2008)
Development of Automated Noninvasive DiskTreadmills for Sleep Deprivation in Mice
STTR Phase I · Department of Health and Human Services (National Institutes of Health) · 2007 · $232,068
Solicitation year 2007 · Research partner: PENN STATE UNIV HERSHEY MED CT
Automated Touchscreen-Piezo Monitoring of Mouse Cognition, Activity and Sleep
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2007 · $200,198
Solicitation year 2007
AUTOMATED EXTRACTION OF METADATA FROM EXPERIMENT DESIGNS
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2005 · $92,093
Solicitation PHS2005-2 (2005)
High throughput screen of behavior using piezo-imaging
SBIR Phase II · Department of Health and Human Services (National Institutes of Health) · 2005 · $744,109
Solicitation PHS2005-2 (2005)
Showing the 25 most recent of 27 awards.
